TrialBMC urology2012

Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium.

Maria E Goossens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.